R emodeling a fetal heart into an adult heart is a complex process and relies on important transitions that are triggered soon after birth. During this early postnatal stage, the heart undergoes a switch in substrate utilization to catabolize fatty acids, and carbohydrates become a secondary source of energy. 1,2 Failure to enact this metabolic switch in mice is marked by cardiac defects and a lifespan of up to 2 weeks. 3, 4 Apart from the metabolic switch, the early postnatal stage is also marked by a switch in the mode of cardiac growth. Cardiac myocytes largely cease proliferation at approximately postnatal day (P) 4 (P04) and undergo hypertrophic growth, leading to an increase in diameter and mass. 5 In mice, physiological myocyte hypertrophy between P05 and P14 results in a nearly three-fold increase in heart weight. 6 Furthermore, mitochondrial density doubles in cardiac myocytes during early postnatal development, and the small, round, and tubular mitochondria that are found in fetal hearts are re-formed into large ovoid and rectangular mitochondria. 7, 8 This change in mitochondrial shape is paralleled by reorientation of mitochondria such that there is larger contact surface and closer proximity between mitochondria and the myofibrils and between mitochondria and the sarcoplasmic reticulum, a transition that is noted to take place at approximately P07 in mice. 9 This histological evidence suggests that mitochondrial remodeling is important for the passage of the heart from a fetal state to an adult state.
identity at the amino acid level, and in several contexts they exhibit functional overlap or complementation in mediating outer mitochondrial membrane fusion. [13] [14] [15] [16] The molecular characterization of mitofusins has been instrumental in elucidating the significance of mitochondrial dynamics, an enigmatic process that involves the flow of mitochondrial matter through merging, splitting, and transposition of mitochondria. 17, 18 Mitochondrial dynamics have implications in many aspects of mitochondrial function 19 and appear to be particularly important in mitochondrial quality control, the pathway that selectively separates out defective mitochondria for subsequent elimination. 20, 21 Importantly, the dynamic behavior of mitochondria is not the same in all cell types and is strongly influenced by the intracellular motility and the cytoskeleton dynamics. [22] [23] [24] Along these lines, the striated contractile cells of the adult heart and skeletal muscle have a very rigid cytoskeleton and their mitochondria are stationary. 25, 26 Nevertheless, the expression of Mfn-1 and Mfn-2 is very robust in these cells with immotile mitochondria, indicating that mitofusins are still biologically important.
To address the functional significance of mitofusins in striated tissues, several laboratories have pursued the conditional inactivation of Mfn-1 and Mfn-2 in the skeletal and cardiac muscle of mice. So far, it has been found that both Mfn-1 and Mfn-2 are necessary for the maintenance of the mitochondrial genome in skeletal muscle. 27 Furthermore, Mfn-2 in skeletal muscle is important in preserving insulin sensitivity and repressing oxidant stress. 28 Regarding the heart, both Mfn-1 and Mfn-2 are shown to be important during early embryonic cardiac development, and in adulthood they protect against long-term cardiac dysfunction. 29 Our studies with cardiomyocyte-restricted mitofusin knockouts have focused on the identification of common as well as distinct properties of Mfn-1 and Mfn-2. Work with the Mfn-2-deficient strain showed this isoform to be required for suppressing mitochondria from undergoing excessive growth in cardiomyocytes. 30 In contrast, analysis of the Mfn-1deficient strain showed that this isoform operates in the reverse mode, ie, Mfn-1 protects from excessive shrinkage/fragmentation of the mitochondria. 31 Another finding from these studies was that Mfn-1-or Mfn-2-deficient cardiomyocytes contain mitochondria that are relatively impervious to injurious stimuli such as Ca 2+ and reactive oxygen species overload. 30, 31 High doses of these stressors are known to target the mitochondrial boundaries and cause organelle dysfunction by triggering mitochondrial permeability transition. 32 The resistance to mitochondrial permeability transition was detectable in both Mfn-1-or Mfn-2-deficient mitochondria, suggesting a direct relationship between mitochondrial membrane fusion and permeabilization. 30, 31, 33 Finally, these studies showed that the baseline heart function is not severely impacted by the deletion of either Mfn-1 or Mfn-2 in adult animals. 30, 31 In this report, we present work regarding the dual deletion of Mfn-1 and Mfn-2 in cardiac myocytes. We show that permanent inactivation of mitofusins in cardiomyocytes during midgestation has profound effects on the function of the early postnatal heart. Our findings also show that cardiac Mfn-1 and Mfn-2 have important roles for survival postnatum and provide evidence for the significance of mitochondrial remodeling during this particular developmental stage.
Methods
Detailed methods are provided in the Online Data Supplement.
Genetically Engineered Mice
Mice had a mixed background containing 129S, Black-Swiss, and C57Bl/6. Littermates with the appropriate genotypes were used in all experiments. The cre-mediated recombination of loxP sites excises exons encoding key residues of the G1 motif of the GTPase domain of Mfn-1 (exon 4) or Mfn-2 (exon 6). 34 Cardiac myocyte-specific cre expression was driven by a constitutive Myh6 promoter (active during embryogenesis) or a modified estrogen receptor that was inducible (active on injection with raloxifen). For studies with adult animals, male littermates were used. Animal euthanasia and tissue collection were performed according to protocols approved by the Institutional Animal Care and Use Committee of Boston University School of Medicine.
Physiological Studies
Adult animals were lightly anesthetized before undergoing echocardiography or hemodynamic analysis, as previously described. 30 Echocardiography of neonates was performed during the conscious state. The neonatal ECGs were obtained as previously described 35 with the aid of light isoflurane anesthesia delivered through a mouth/nose cone.
Results

Mitofusins Have Redundant Functions in Cardiomyocytes That Are Important for Survival Postnatum
We have previously described mice with conditional deletions of Mfn-1 or Mfn-2 in cardiomyocytes and found that singleknockout mice are viable and fertile and display a normal basal heart function as young adults. 30, 31, 36 Given the high similarity between Mfn-1 and Mfn-2, we asked whether they could operate interchangeably in cardiac myocytes, and therefore attempted to generate double-knockout (DKO) animals in both the adult and embryonic hearts. Previously, it has been shown that depletion of mitofusins by the tamoxifen-activated protein modified estrogen receptor (Mer) CreMer leads to progressive decreases in fractional shortening (FS) in adult mice. 29 In agreement with this study, we found that mitofusin depletion in mice (herein referred to as Mer-DKO) leads to cardiac dysfunction evident at 8 weeks after raloxifen administration and death ensues 3 weeks later (Online Figure I) . These observations confirm the notion that Mfn-1 and Mfn-2 operate redundantly and are essential for cardiac function and survival in adulthood.
To examine the roles of Mfn-1 and Mfn-2 in cardiomyocyte specifically during late gestation/early postnatal development of the heart, we used the Myh6-cre transgenic line to selectively disrupt the mfn-1 and mfn-2 loci of mice (genotype: Mfn-1 F/F ; Mfn-2 F/F ; Myh6-cre +/− , herein DKO). Genotyping of 104 animals from multiple litters at their weaning (P21) did not detect any mice with the desired genotype (Online Table I) , Myh  myosin heavy chain  DCM  dilated cardiomyopathy  Mfn  mitofusin  mtDNA  mitochondrial DNA  GTP  guanosine triphosphate  PGC-1 peroxisome proliferator-activated receptor γ coactivator 1 September 28, 2012
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suggesting that DKO mice were not viable and that all four mitofusin alleles were needed for survival either during midgestation or during the first 3 weeks of life. In this analysis, it was found that even one functional allele (regardless of whether this is from Mfn-1 or Mfn-2) is sufficient to compensate for the absence of the other three alleles. Mice harboring one functional mitofusin allele (Mfn-1 F/F ; Mfn-2 +/F ; Myh6cre +/− or Mfn-1 +/F ; Mfn-2 F/F ; Myh6-cre +/− ; collectively referred to as monoallelic) survive through adulthood, although their hearts exhibit chamber enlargement, decreased FS, and alterations in their elastic properties (Online Figure II) .
To test the possibility that DKO mice die during gestation, we genotyped mice at birth (P0). The analysis of a total of 134 pups obtained from 15 litters indicated that DKO mice were born at the expected Mendelian ratios (Online Table II ). This rules out the possibility that DKO mice die during gestation, which could potentially lead to their resorption in utero. Furthermore, of the 32 DKO pups identified, all 32 were alive. Therefore, DKO mice survive through the embryonic and fetal stage and are born alive in the expected Mendelian ratios. However, because none of the DKO animals are recovered at P21, we conclude that death occurs at an early postnatal stage and that even a single mitofusin allele in cardiac myocytes is sufficient for survival through this period.
Cardiomyocyte-Produced Mitofusin Expression Is Elevated During Postnatal Heart Development
To determine the temporal pattern of mitofusin expression in the developing heart, we examined embryonic and early postnatal hearts (ie, embryonic day [E] 15.5 through P07) for the expression of Mfn-1 and Mfn-2. One finding of the transcriptional analysis is that in wild-type (WT) hearts both Mfn-1 and Mfn-2 transcripts are produced at relatively low amounts during gestation (E15.5 and E18.5; Figure 1A and 1B) but undergo more than two-fold upregulation at approximately the time of birth (P0 and P01). Furthermore, significant transcriptional upregulation of mitofusins also is evident at P07 ( Figure 1A and 1B). In contrast, in DKO hearts, the levels of Mfn-1 and Mfn-2 were found to be downregulated as early as E15.5 and persisted to these very low levels throughout the remaining gestational and postnatal period examined ( Figure 1A and 1B, open bars). Consistent with the low levels of mitofusin expression already at E15.5 in DKO hearts, previous reports have shown that the Myh6 promoter is activated in early myocytes at E9.5 and that genetic recombination using the Myh6-cre construct can be achieved by E12.5. 37, 38 The residual levels of mitofusin transcripts detected in DKO extracts likely arise from nonmyocyte cardiac-resident cell populations that do not express the Myh6-cre transgene; however, this analysis reveals that the bulk of mitofusin expression in the postnatal heart is attributable to the cardiomyocyte population ( Figure 1A and 1B). Taken together, the analysis of mitofusin expression in WT and DKO hearts indicates that gene ablation takes place during midgestation and provides evidence for transcriptional activation of mitofusin genes during postnatal heart development.
Myh6-cre-Mediated Ablation of Mitofusins Spares the Heart From Gestational Developmental Abnormalities and Dysfunction
To test whether mitofusin ablation in this model is potentially associated with developmental abnormalities, we examined WT and DKO hearts from E15.5 through P03. This analysis showed that the expected developmental increases in cardiac size that occur in WT hearts also take place in DKO hearts ( Figure 1C ). To assess a potentially deleterious effect in heart function that may have arisen in DKO hearts during midgestation or at the time of birth, we used echocardiographic analysis for newborn mice. The morphometric data were obtained by examining conscious mice on the day of their birth (P0). As shown in Figure 2 , the evidence is in agreement with the notion that P0 DKO hearts are functionally equivalent to WT hearts (Figure 2A and 2B). More specifically, we identified close similarities between WT and DKO mice in terms of their heart rate, their FS, and a number of other parameters related to the structure and the relaxation/contraction of the heart, including left ventricular (LV) wall thickness, LV volume, and mitral and pulmonic valve flow velocities ( Figure 2C-2J ). Taken together, the absence of any evidence for heart dysfunction indicates that midgestational ablation of mitofusins, selectively in cardiac myocytes, spares the heart from significant developmental abnormalities and dysfunction through birth.
Morphological Features of P0 Mitochondria
Recently, we have demonstrated that absence of either Mfn-1 or Mfn-2 in adult cardiac myocytes leads to characteristic but disparate mitochondrial morphologies. 30, 31 Although loss of Mfn-2 creates larger mitochondria, loss of Mfn-1 has the opposite phenotype and creates smaller mitochondria. To determine the impact of combined Mfn-1 and Mfn-2 ablation in cardiomyocyte ultrastructure, we examined heart sections from P0 hearts by electron microscopy (Online Figure III) . Wild-type P0 cardiomyocytes contain tubular and ovoid mitochondria and sometimes elongated vermiform mitochondria (Online Figure IIIA) . The electron-dense WT mitochondria are dispersed among myofibrils and the P0 myofibrils also exhibit irregular orientations inside the cytoplasm (Online Figure IIIC ), and they have yet to assume the linear arrangement, that is typical for myofibrils in longitudinal sections of fully developed hearts. Lipid droplets were frequently observed in other regions of the cytosol. In P0 DKO cardiomyocytes, the cytoplasm appears to be poorly organized, similar to the WT cytoplasm. However, a large proportion of mitochondria assumes a spherical configuration (Online Figure IIIB) . In addition to a transition to a spherical state, DKO mitochondria undergo enlargement and diminution, and big mitochondria are found to be intermixed with small mitochondria (Online Figure IIID and IIIE). Tubular mitochondria were also detected, but less frequently (Online Figure IIID) . By analysis of the micrographs, we found that the mitochondrial volume density was significantly elevated in DKO (Online Figure  IIIF) , indicating the presence of higher numbers of mitochondria in these hearts. Nevertheless, P0 DKO mitochondria do not exhibit significant defects in their internal structure and they maintain an electron-dense appearance. Furthermore, the formation of myofibrillar bundles does not appear to be impaired in DKO hearts at P0. Consistently, the volume density of the myofibrillar compartment in these hearts appears to be normal (Online Figure IIIG) . In summary, ultramicroscopy of the P0 DKO cardiac myocytes revealed mitochondrial alterations in terms of the structure and number of mitochondria, but a normal assembly of the contractile elements.
Loss of Mitofusins From Myocytes Leads to Heart Failure by P07
Both Mfn-1 and Mfn-2 genes are markedly upregulated in the heart between P0 and P07 ( Figure 1A ). We therefore investigated the cardiac phenotype of DKO mice at P07. As shown in Figure 3 , echocardiographic assessment of conscious WT and DKO mice at P07 revealed that the latter underwent a very rapid and severe dilated cardiomyopathy (DCM). The wall motion in DKO hearts was drastically attenuated and the blood flow in the LV chamber was not properly maintained ( Figure 3A and 3B). Consistently, significant alterations in different quantitative parameters were detected at P07. As such, the heart rate was lower in DKO hearts and their FS was markedly decreased ( Figure 3C and 3D). Furthermore, the internal diameter of the LV was increased, whereas its walls underwent significant thinning ( Figure 3E and 3F). The calculated diastolic volume of the LV underwent a nearly three-fold increase in DKO hearts compared with WT, in agreement with the DCM phenotype ( Figure 3G ). At the same age, DKO had abnormal ECG patterns, where the QRS complex was evidently altered ( Figure  3H ). Taken together, these characteristics are indicative of the detrimental remodeling and poor pumping function of the DKO heart. The early temporal manifestation of this phenotype (ie, between P01 and P07) suggests that the overlapping actions of Mfn-1 and Mfn-2 in cardiomyocytes are essential during the developmental remodeling of the early postnatal heart.
Rapid Decline in Survival and Cardiac Defects in Mice Lacking Mitofusins
Based on the genotype frequencies (Online Tables I and  II) , it is apparent that although DKO mice are born alive, they die before their weaning (P21). To define the profile of this premature lethality in greater detail, we performed genotyping on newborn WT and DKO mice and monitored them until weaning and death, respectively ( Figure 4A ). From the resulting survival curve, it is evident that DKO mice start to die as early as P06 and none survive beyond P16 ( Figure  4A , red trace). The majority of the DKO mice die between P08 and P10. This pattern is consistent with the evidence from echocardiography that detected no signs of heart dysfunction at P0 but identified DCM by P07 (Figures 2 and 3 ). Thus, DKO mice likely undergo premature death because of DCM and heart failure. DKO mice typically display a decline in body condition that becomes evident at approximately P06 and P07 ( Figure 4B ). The body weight of DKO mice was found to be significantly lower compared with WT littermates at that age ( Figure 4D ). On autopsy at P04, some DKO hearts displayed readily evident abnormalities ( Figure 4C and 4F). At that age, the DKO heart was flaccid and the ventricular walls appeared to fold inwardly ( Figure 4C , right panel, arrowhead points to the right ventricular wall). This was in contrast to the round and well-shaped WT ventricular walls. In addition, the left atrium appeared to undergo hypertrophy and retained blood in the form of a clot ( Figure 4C , arrow).
P04 DKO hearts displayed increases in the right ventricular and LV cavities, as well as substantial thinning of the walls ( Figure 4F , arrowhead pointing to the interventricular septum), an observation consistent with the DCM phenotype detected by echocardiography ( Figure 3 ). Furthermore, patches of collagen deposition could be observed in the DKO myocardium, suggestive of the ongoing cardiac fibrosis ( Figure 4F , white arrow). The histological analysis also confirmed the atrial enlargement and congestion ( Figure 4F , dark arrow). Despite these adaptations, the total heart weight did not differ significantly between WT and DKO mice that underwent autopsy at P04 (results not shown) and P07 ( Figure 4E ). Consistent with the onset of cardiopathic stimuli in DKO heart, the transcript levels of myocardial stress indicators Anp and Bnp were markedly elevated, whereas the transcript levels of the different myosin heavy chain isoforms and inhibitory troponin isoforms were uniformly downregulated in P07 DKO hearts (Online Table III ). Interestingly, there was no evidence for significant activation of apoptosis in P07 DKO hearts (Online Figure IV) .
Postnatal Structural Defects in the Mitochondrial and Myofibrillar Compartments of the Mfn-1/Mfn2 Double-Deficient Cardiomyocytes
Because the absence of mitofusins from cardiac myocytes led to a dramatic decline in heart function within the first week of postnatal life, we examined the ultrastructure of cardiac sections by electron microscopy at P07 to obtain clues regarding the mechanisms that underlie this dysfunction. Imaging of WT myocardium revealed that myocytes at this stage exhibit extensive features that are reminiscent of adult cardiac myocytes, ie, the actin/myosin banding becomes readily evident and the myofibrillar bundles increase in diameter and assume a linearized orientation and run parallel to the longitudinal axis of the myocyte ( Figure 5A ). The WT mitochondria at this stage have mostly rectangular or spherical shapes, whereas the tubular mitochondria are less frequent. Coincident with the linear orientation of myofibrils, P07 mitochondria are arranged parallel to, and stay in close proximity to, the myofibrils (Figure 5A, 5C, and 5E ). In addition to maintaining close apposition to the contractile elements, P07 mitochondria exhibit tight packing, leaving behind little free cytoplasm. Lipid droplets are also present, appearing as gray or white spots within the mitochondrial conglomerate ( Figure 5C and 5E ).
In P07 DKO hearts, the myocyte structure exhibits marked deviation from that in WT cells. A profound alteration is the high frequency of spherical mitochondria ( Figure 5B ), a feature consistent with previous reports on double-mitofusinnull models in striated muscle. 27, 29 The formation of spherical mitochondria was also observed in P0 DKO cardiomyocytes. Although an increased mitochondrial number was also evident at P0 (Online Figure IIIB , IIID, and IIIE), this did not coincide with major aberrations in the structure and organization of the myofibrils. In P07 DKO samples, the abnormal increase in mitochondrial numbers is still prevalent, but there are regions of cardiomyocytes where the mitochondria appear to displace the myofibrils ( Figure 5B ). Related to this disorganized mitochondrial spreading, the distances between parallel myofilaments increase in DKO sections (compare Figure 5C and 5D, arrowheads). These features were also quantitatively important. Using the grid method to determine how the cell volume is allocated into different compartments, we detected a significant increase in mitochondrial density, which is associated with reduced myofibrillar density in DKO hearts ( Figure 5G and 5H). In addition to the apparent increase in mitochondrial number, a characteristic dysregulation in mitochondrial diameter was observed, whereby unusually large mitochondria coexist with petite mitochondria (Figure 5F, arrows) . September 28, 2012
The mitofusin-null mitochondria presented varying degrees of cristae defects and, as a consequence, the structure of the inner membrane was modestly ( Figure 6B and 6B') or severely ( Figure 6C and 6C') impaired. This pattern of inner membrane dysregulation, as detected in DKO mitochondria, is in sharp contrast to the dense cristae packing that is observed in WT mitochondria at P07 ( Figure 6A) or the WT and DKO mitochondria at P0 (Online Figure III) . Furthermore, the loss of cristae and the decondensation of the matrix appeared to occur similarly among the different sizes of mitofusin-null mitochondria, ie, loss of the inner structure happens regardless of whether the mitochondria have small, intermediate, or large diameters (compare Figure 6A with Figure 6C ).
The mitochondrial boundaries in WT samples are smooth and their shape is defined by subtle changes in membrane curvature ( Figure 6D and 6D') . In DKO samples, however, the boundaries of some mitochondria appear to undergo dramatic changes in curvature and the membranes create finger-like projections ( Figure 6E, 6E', 6G , 6H, and 6I). Furthermore, a single DKO mitochondrion is capable of forming one, two, or three such projections (more typically just one, eg, Figure 6G , asterisk), and these projections appear to push into the membranes of an adjacent mitochondrion, creating an invagination. Consequently, short chains of mitochondria are created where one mitofusin-null mitochondrion extends a projection towards its neighbor ( Figure 6H ). In other situations, the surfaces of adjacent mitochondria undergo even more extreme curvature to form Ω (Ω-like) membrane configurations ( Figure 6G, hash) . The membrane protrusions appear to preferentially form on DKO mitochondria, which exhibit extensive matrix decondensation ( Figure  6E , 6G, 6H, and 6I, asterisks). Nevertheless, not all mitochondria with apparent structural defects form these protrusions ( Figure 6F, dagger) , indicating that the abnormalities in the internal structure of mitochondria (reflecting mitochondrial dysfunction) precede the formation of these membrane deformities.
Finally, DKO sections contained small, vesicle-like organelles that appeared to be voids surrounded by a single membrane ( Figure 6F, arrows) . These vacuoles do not represent lipid droplets because they are smaller in size and they do not exhibit the gray coloration that is typically seen inside the droplet.
Altered Expression of Mitochondrial Biogenesis and Mitophagy Markers in Mitofusin-Deficient Hearts at P07
Forming mitochondria involves the incorporation of de novo synthesized proteins into preexisting mitochondria that replicate their genome and subsequently segregate into daughter mitochondria. However, formation of mitochondria could be counteracted by whole-organelle elimination through mitochondria-directed autophagy (mitophagy). Thus, we analyzed whether these processes were altered, given the severe mitochondrial abnormalities and the appearance of defective mitochondria in DKO hearts at P07. Biosynthesis of new ) and the peroxisome proliferator-activated receptor γ coactivator 1 (PGC-1α). 39 As shown in Online Figure V , the transcript levels of these factors in DKO hearts exhibit little or no changes at P0 or P03. Nevertheless, the majority of these genes become significantly suppressed in P07 DKO hearts ( Figure 7A ). Next, we examined the transcription of genes important in the autophagy pathway. As shown in Online Figure VI , we analyzed genes such as Ulk-1 and Ulk-2 (encoding upstream kinases regulating the initiation of autophagy), Atg-5 and Atg-12 (effectors of autophagosome formation through the Atg-12 conjugation system), LC3-b (component of the Atg-8/LC3 conjugation system), and Atg-6/Beclin-1 (component of the lipid kinase complex). At P0 and P03, these genes did not change significantly in DKO hearts, but at P07 their expression (as well as that of Bnip-3, a candidate mediator of mitophagy) was clearly dysregulated (Online Figure VIC) . Dysregulation also was evident at the level of protein turnover, because the levels of p62 and LC3-II were found to be significantly elevated in P07 DKO hearts ( Figure 7B-7E) . In contrast, the levels of the lysosomal marker cathepsin-D were unaltered ( Figure 7D-7E) . Taken together, these data suggest that in the present model of heart failure, the activity of the mitochondrial biosynthetic machinery is decreased and at the same time the mitochondrial elimination pathway appears to be halted.
Loss of mtDNA and an Impaired Expression of Mitochondrially Encoded Genes in the Mitofusin-Deficient Heart
The transcriptional repression of mitochondrial and metabolic genes is frequently observed in the context of heart failure. 40 We examined the transcription of genes encoding essential components of the mitochondrial electron transport chain in P0, P03, and P07 DKO hearts. As shown in Online Figure VII in a progressive manner (Online Figure VIII) . Nd-5 and Cyt-b that are encoded by the mitochondrial genome were the only genes to be downregulated already by P0 in DKO hearts (Online Figure VII) , thus preceding the onset of severe heart failure. Consistent with these early reductions, Nd-5 and Cyt-b transcripts were robustly downregulated in P07 DKO hearts ( Figure 8A and 8B) .
Previous work identified mitofusins to be important determinants of mtDNA maintenance in skeletal muscle. 27 In light of the early reductions in the expression of Nd-5 and Cyt-b, we quantified the levels mitochondrial (mt) DNA in heart extracts from WT and DKO mice using real-time polymerase chain reaction. Regarding WT samples, these analyses showed that in the normally developing postnatal heart there is a more than two-fold increase in the levels of mtDNA between P03 and P07 hearts, consistent with the ongoing mitochondrial biogenesis ( Figure 8C, filled bars) . In DKO samples, however, the amount of mtDNA was slightly but significantly decreased at P03 and exhibited substantially more severe reductions by P07 ( Figure 8C, empty bars) . Thus, the reduction in the mtDNA of postnatal DKO hearts occurs in a progressive manner and generally coincides with or precedes the onset of heart failure. Consistent with mtDNA decrease, the protein levels of subunit 1 of the cytochrome c oxidase (COX-1, which is a mitochondrially encoded polypeptide) are severely reduced at P07 ( Figure 8D ). However, the protein levels of subunit α, a component of the F 1 -ATPase, which is encoded by the nuclear genome, displayed little or no reduction in P07 DKO hearts ( Figure 8D ). Consistent with a reduction in COX-1 protein levels, the in situ enzymatic activity of cytochrome c oxidase was markedly reduced in DKO heart sections, as indicated by the paler staining with DAB in cytochrome c oxidase/succinate dehydrogenase staining assays ( Figure 8E ).
Mitochondria from WT and DKO hearts at P06 and P07 were isolated and assessed for their capacity to produce ATP. In the course of mitochondrial isolation, we found that the mitochondrial protein yield is significantly decreased in DKO preparations (Online Figure IXA) despite the observed increase in mitochondrial number by electron microscopy (Figure 5G ). This indicates that the number of extractable mitochondria is markedly lower in P07 DKO hearts, suggesting that the defective mitochondria observed by EM are structurally unstable or that the protein content per mitochondrion is reduced in the DKO. Given this baseline difference, we adjusted the dilution in the different suspensions to contain equal amounts of mitochondrial protein. Assessment of the citrate synthase activity in the extracted mitochondrial samples showed the mitochondrial content to be equal in the different preparations after this adjustment (Online Figure IXB) . Next, mitochondria were assessed for their ability to synthesize ATP in the presence of different substrates and after the addition of exogenous ADP. Surprisingly, the maximum rates of ATP synthesis did not differ significantly between WT and DKO mitochondrial preparations (Online Figure IXC-F) . In addition, measuring total ATP content in whole hearts did not detect significant decreases in P07 DKO hearts, suggesting that the pool of cardiac ATP is maintained even in the context of severe cardiac dysfunction (Online Figure IXG) . Taken together, these findings indicate that despite a pervasive mitochondrial deficit, the DKO hearts contain sufficient functionally competent mitochondria that allow the heart to maintain normal ATP levels at this time point (P07).
Discussion
The present study highlights the importance of mitofusins (Mfn-1 and Mfn-2) in the early postnatal heart. Mitofusins are mechanoenzymes that support the mitochondrial continuum in cells by catalyzing the integration of the outer mitochondrial membrane, and they are abundantly present in human and other mammalian hearts. [41] [42] [43] [44] The particularly high expression of mitofusins in this very oxidative organ is not surprising because the heart exhibits an extremely high mitochondrial content, eg, 25% in humans and 38% in mice. 45 Using a cell-specific gene knockout approach, we find that the combined inactivation of Mfn-1 and Mfn-2 from cardiac myocytes results in a rapidly evolving, early postnatal phenotype that is characterized by major abnormalities in mitochondrial structure, DCM, and premature death during the second week of life.
The gross morphology of DKO hearts at prenatal developmental stages (eg, E15.5 and E18.5) does not differ significantly from WT hearts. Furthermore, there are no structural or functional differences between WT and DKO hearts at P0, although changes in mitochondrial morphology are already evident. At P0, DKO mitochondria assume spherical shapes and are heterogeneous in size. Work with single knockouts showed that cardiac myocytes lacking Mfn-1 have mitochondria with diminished diameters, whereas myocytes that lack Mfn-2 have mitochondria with increased diameters. 30, 31 In what appears to be a combination of these phenotypes, we find here that cardiac myocytes lacking Mfn-1 and Mfn-2 contain both enlarged and small mitochondria at P0. Another characteristic of the P0 DKO hearts is the increase in mitochondrial volume density. Increased mitochondrial volume density is also detected in skeletal muscle after dual mitofusin deficiency. 27 These findings indicate that the absence of mitofusins favors the expansion of mitochondrial numbers. Along these lines, the increase in mitochondrial numbers may represent an adaptation of the muscle to compensate for dysfunctional mitochondria. However, it is important to note that there are no apparent alterations in the internal structure of P0 DKO mitochondria and no matrix decondensation is observed at this time point. Additionally, myofibril volume density is unaltered, consistent with the finding that heart function of DKO hearts is normal at P0. Thus, it appears that although P0 DKO hearts have preexisting abnormalities in mitochondrial structure and number, they maintain short-term functionality before being exposed to the postnatal rigors.
In the developmental window between P0 and P07, the transcripts encoding Mfn-1 and Mfn-2 are markedly upregulated in WT but not in DKO hearts. At the P07 time point, DKO hearts exhibit hallmarks of DCM, including decrease in FS, increase in LV diameters, thinning of ventricular wall, and abnormal ECG pattern. These features are also accompanied by poor body condition, atrial congestion, focal collagen deposition, upregulation of the stress markers Anp and Bnp, and a decline in survival, and no live DKO animals are recovered beyond P16.
The DKO failing hearts present some striking and unique characteristics in cardiac myocyte and mitochondrial ultrastructure. As mentioned, mitochondria in double-deficient hearts appear to undergo unrestrained expansion and occupy a significantly larger portion of the cellular volume. This is accompanied by defects in the organization of the contractile apparatus and a state of structural disarray specifically in P07 DKO hearts. In addition to appearing as exceedingly small or large spherical organelles, P07 DKO mitochondria have further abnormalities, such as matrix decondensation and loss of cristae structure. In P07 DKO cells, many dilated/swollen mitochondria are evident. They coexist with unusually small round organelles with little or no inner membrane structure. One possibility is that these voids result from petite mitochondria that underwent extreme degeneration and cast off their internal or external membrane, or they could represent remnants of late-stage dysfunctional mitochondria that collapse into multiple fragments. Apart from its important role in biochemical pathways and energy conversion, the inner mitochondrial membrane is an integral and quantitatively important part of the myocyte. Therefore, its extreme degeneration/loss that is detected in many P07 DKO mitochondria could be, by itself, an important element contributing to cell and organ dysfunction. Another interesting microscopic observation is that the boundaries between adjacent P07 DKO mitochondria are sometimes found to rearrange into extreme curvatures and form finger-like protrusions. Chains of mitochondria exhibiting these characteristics are uniquely present in DKO myocytes. We currently interpret the aforementioned projections to reflect abortive fusion attempts of mitofusin-null mitochondria. It can be suggested that in the absence of mitofusins, other unknown factor(s) are recruited or become activated as an utmost effort to induce mitochondrial fusion or tethering.
Soon after birth, the heart undergoes rapid increases in mitochondrial content and respiratory function. 46, 47 These adaptations are necessary for postnatal cardiac growth and for effective support of the pulmonary and systemic circulation. To coordinate these changes, the heart relies on a specialized transcriptional circuit, into which the coactivator Pgc-1 operates as a central switch. 48, 49 Consistent with the important role of Pgc-1 in postnatal heart growth, mice with total absence of Pgc-1 (ie, Pgc-1α −/− and Pgc-1β −/− ) are born in the expected Mendelian ratios but die soon after birth. 4 Similarly, we demonstrate here that mice lacking Mfn-1 and Mfn-2 in cardiac myocytes survive embryonic development and start to die largely during the second week of life. Moreover, we find that the expression of Mfn-1 and Mfn-2 in WT hearts is induced from birth and onward, a period coinciding with the activation of Pgc-1 in the heart. 50 The similarities in the temporal pattern of lethality between the two knockout models (ie, Pgc-1 null versus mitofusin null) may imply a functional relationship between Pgc-1 and mitofusins. Mitofusins are demonstrated to be transcriptionally activated by Pgc-1 in muscle cells. [51] [52] [53] Thus, it can be suggested that mitofusins are putative downstream effectors in the mitochondrial biogenic program that is activated by Pgc-1 in postnatal cardiac myocytes.
Apart from the early postnatal phenotype, we also provide evidence for a necessary role of mitofusins in adult mice. This is in agreement with an independent study focusing on the role of mitofusins in the heart. 29 Using the MerCreMer, the earlier study reported that the disruption of mitofusins in adult hearts leads to mitochondrial fragmentation and gradual deterioration of heart function. 29 Consistent with these findings, using the same Cre-expressing strain, we show reductions in FS and progressive lethality in mitofusin double-deficient animals (Online Figure I ). Chen et al 29 also reported that cardiac ablation of Mfn-1 and Mfn-2 during embryonic development causes lethality at approximately E10.5. Interestingly, this differs from the early postnatal lethal phenotype that we detect here. A possible explanation for obtaining dissimilar results could be because different promoters were used to induce cre expression in the 2 studies. The study by Chen et al used Nkx-2.5cre known to be active in cardiac progenitor cells and therefore has the potential to recombine loxP sites in all cardiac cells, including cardiomyocytes and endothelial, smooth muscle, and mesenchymal cells of the heart. 54 By contrast, the expression of the Myh6-cre transgene used in the current study is restricted only to cardiac myocytes. 37, 54, 55 Thus, one possibility is that the embryonic lethality observed by the earlier study is attributable to the inactivation of mitofusins in the nonmyocyte compartment of the heart. In this regard, mitofusins have been shown to be important for vascular endothelial cell differentiation, survival, and function. 56 Apart from differences in cell specificity, there are differences in the timing of mitofusin inactivation between the studies. Nkx-2.5cre begins gene excision at E7.5, 57 whereas Myh6cre begins excision at E9.5. Thus, an alternative possibility is that early inactivation of mitofusins by Nkx-2.5cre elicits a severe effect in the developing heart because this period encompasses important transitions such as heart tube formation and looping. However, the utilization of Myh6-cre becomes useful in interpreting the role of mitofusins, specifically in the cardiac myocyte, during midgestation and early postnatal development of the heart.
The evidence from this study suggests that mitofusins, and by extension mitochondrial fusion, are important for the formation of functional mitochondria in cardiac myocytes during the period from P0 to P07. Conceptually, mitochondrial fusion is beneficial during this period of unprecedented high energetic demand because it allows the diffusion of metabolites in different compartments of the mitochondrial network and promotes more efficient energy conversion. 58 In this regard, it is demonstrated that fusion is activated during mild intracellular stress or nutrient deprivation to enhance mitochondrial ATP production. 59, 60 Fusion is also suggested to be important for genome exchange between mitochondria and to facilitate mtDNA complementation. 61 Consistent with a relationship between mitochondrial fusion and mitochondrial genome maintenance, previous work has established a link between mitofusins and mtDNA copy number in skeletal muscle. 27 In agreement, we found that loss of mitofusin activity is accompanied by reductions in mtDNA. This reduction in mtDNA appears to preexist cardiac dysfunction, although it is likely to be further exacerbated as the hearts begin to fail. September 28, 2012
It is also possible that mitofusins are important during the P0 to P07 developmental stage through mechanisms that do not involve fusion and content exchange between mitochondria. One possibility is that mitofusins allow actively proliferating mitochondria to establish connections with the cytoskeleton and correctly position themselves into the myofibrillar blueprint during cardiomyocyte postnatal development. Along these lines, molecular defects in the assembly of the cytoskeleton in cardiac myocytes are common causes of DCM in mice and in humans. [62] [63] [64] We found that the loss of mitofusins is accompanied by rapid and lethal DCM, which may indicate an underlying defect in cytoskeletal function. The possible interaction of mitofusins with the cytoskeleton has been recently addressed in neurons, where Mfn-1 and Mfn-2 were shown to interact with adaptor proteins that tether the outer mitochondrial membrane to microtubules. 65 Regarding striated muscle, the interaction of mitochondria with intermediate filaments is noted and genetic defects in the assembly of intermediate filaments are sometimes accompanied by dramatic changes in mitochondrial morphology in hearts. 66, 67 Therefore, there is emerging evidence to support a potential role of mitofusins at the mitochondrion/cytoskeleton interface and perturbations in this association may have contributed to the developmental abnormalities that we identify here.
In both the P0 and P07 DKO hearts, there is an overpopulation of mitochondria, indicating altered mitochondrial biogenesis. This increase in numbers could reflect a compensatory response to an underlying mitochondrial dysfunction. Nevertheless, there is no significant evidence for the activation of biosynthetic pathways regulating the formation of new mitochondrial components. This is supported by the finding that in DKO hearts the Pgc-1 transcriptional pathway is either unchanged or suppressed, as is the transcription of many genes that encode key mitochondrial proteins. Increased mitochondrial numbers in DKO hearts may originate from a defect in the elimination of excessive mitochondria through mitophagy and recent work indicates that Mfn2 is important for the autophagy pathway. 68, 69 However, in the present model, we identify significant evidence of altered autophagy that coincides with the onset of heart failure, but not before. This evidence includes aberrant gene expression of key autophagy mediators (ie, Ulk-2, Atg-5, Atg-12, Beclin1, and Bnip-3) and accumulation of p62 and LC3-II proteins at P07. Thus, heart failure at P07 appears to be associated with a diminished ability to synthesize new mitochondrial components as well as with a reduction in the ability to remove mitochondria. Given this reciprocal relationship, it could be suggested that these alterations (ie, decreased autophagy and a concomitant decrease in de novo biogenesis) may be part of a global mechanism that operates to maintain or prolong cardiac homeostasis in the stressed heart. It is widely appreciated that the heart has a remarkable ability to maintain stable levels of ATP despite varying workloads. 70 Here, we found that despite the drastic mitochondrial deficit of P07 DKO hearts, isolated mitochondria were capable of producing maximum amounts of ATP and the total levels of ATP in these hearts did not change. Thus, it is tempting to speculate that ATP levels are maintained in the face of mitofusin deficiency by mechanisms that globally adjust rates of mitochondrial biogenesis and mitophagy as the heart begins to fail.
